Background According to previous reports, the risk of disability as a result of diabetes varies from none to double. Disability is an important measure of health and an estimate of the risk of disability as a result of diabetes is cr ucial in view of the global diabetes epidemic. We did a systematic review and meta-analysis to estimate this risk.
Introduction
The prevalence of diabetes worldwide has more than doubled over the past three decades, with an estimated 347 million adults living with diabetes in 2008. 1, 2 Diabetes increases the risk of disabling disorders including cardiovascular disease, 3 retinopathy, 4 renal failure, 5 and peripheral vascular disease. 4 Physical disability 6 is a useful measure of the overall eff ect of diabetes on health. Disability can be defi ned in several ways, including diffi culties with activities of daily living (ADL), diffi culties with instrumental activities of daily living (IADL), and mobility limitations. 7 In 2004, the worldwide direct costs of all disability to individuals was between 11% and 69% of income and costs to the governments of countries in the Organisation for Economic Co-operation and Development accounted for roughly 10% of public social spending. 8 The risk of disability associated with diabetes has been studied previously [9] [10] [11] [12] with results ranging from no association to a doubling of risk. Epidemiological studies have varied in design, how diabetes was assessed (eg, by doctor or self-reported), defi nition of disability, and length of follow-up. Few studies have analysed the moderating eff ects of diabetes duration or glycaemic control and little is known of the risk of disability associated with measures of prediabetes-ie, impaired glucose tolerance or impaired fasting glucose. Although two reviews 6, 13 have qualitatively summarised the evidence of a relation between diabetes and disability, no meta-analysis has pooled estimates of this risk. Accurate estimation of the risk of disability associated with diabetes is pivotal to understanding the health needs of the ageing population.
We did a systematic review and meta-analysis to estimate the magnitude of the relation between diabetes and prediabetes and the risk of disability, and to analyse the potential moderating factors of this association, particularly sex, duration of diabetes, and glycaemic control.
Methods

Systematic review
The protocol for this systematic review and metaanalysis has been published previously. 14 This study was done in accordance with the PRISMA 15 and MOOSE 16 guidelines. We searched Ovid, Medline, Embase, Cochrane Library, and Cumulative Index to Nursing and Allied Health Literature up to Aug 8, 2012 for reports published in English. We searched for "diabetes", "glucose intolerance", "diabet*", "glucose intoleran*", and "impaired glucose toleran*" as medical subject headings and keyword terms in the title, abstract, and text, combined with the operator "OR".
We included all types of diabetes irrespective of cause, which includes gestational, type 1, type 2, insulindependent, insulin-requiring, and insulin-depleted diabetes. We then combined diabetes terms with the operator "AND" for disability terms: "activities of daily living", "disabled persons", "mobility limitation", as well as keyword terms "disabl*", "disabiliti*", "limit*", "impair*", "mobili*", "ambulat*", "activit*", and "function*". All disability terms were combined with the operator "OR". The search was limited to casecontrol, cohort, and cross-sectional studies, and clinical trials of adults older than 19 years. We also searched the reference lists of included studies and reviews for relevant reports. Two investigators independently reviewed the retrieved articles in two stages; fi rst assessing relevance from the title and abstract and if relevance was still unclear, the full text was read. Any disagreement about inclusion was referred to a third reviewer and resolved by discussion.
We only included studies published in peer-reviewed journals that reported diabetes status, disability, and an estimate of risk for the association between diabetes and disability compared with no diabetes. Measures of disability included single and composite measures of disability based on ADL, IADL, or mobility.
We excluded studies of subgroups of patients with specifi c illnesses, or undergoing specifi c medical or surgical procedures, and studies of nursing home residents. We excluded disability measures that were defi ned by disturbances in cognitive function because our aim was to study physical disability. We also excluded studies reporting disability as a continuous measure.
When studies analysed the same population, we excluded the study with the weaker study design-ie, cohort studies were preferred to cross-sectional studies. If two cohort studies used the same baseline population, we included the study with the longer follow-up.
Data collection
Data from each study were independently extracted by two reviewers and cross-checked by EW. We recorded study design, baseline study year, length of follow-up, sample size, response rate, study characteristics, mean age, proportion of men, method used to ascertain diabetes and disability status, disability incidence, confounders, and eff ect size with 95% CIs of the association between diabetes and disability. If information was missing, we contacted the authors. We extracted sex-specifi c risk estimates when available. We preferentially extracted the risk estimates from models that adjusted for age, sex, education, and smoking but not for chronic diseases that might be part of the causal pathway.
Statistical analysis
We pooled risk estimates according to assessment of disability (ADL, IADL, or mobility) and the type of risk estimate reported (odds ratio [OR] or risk ratio [RR]). Generally, studies dichotomised disability at the level of at least some diffi culty in at least one activity. Because defi nitions of severity of disability varied between studies, we analysed severity of disability according to the following hierarchy (least to most disabled): 17 mobility disability preceding IADL disability, and IADL preceding ADL disability. As a conservative approach, when a risk estimate was reported for a composite measure of disability, we included it in the analysis following the same hierarchy-eg, if a composite measure included a mobility measure, the study was analysed as mobility disability because mobility disability is fi rst in the hierarchy.
We were unable to combine ORs and RRs because we assumed that disability is a common outcome and therefore the OR and RR will not approximate each other. 18 We subdivided the pooled ORs by study design. We calculated the log of the OR or RR, with standard errors, for all point estimates and 95% CIs using the generic inverse variance method. We used a random eff ect model because we expected the data to be heterogeneous across studies.
We compared pooled ORs for diff erent study designs with the test for subgroup diff erences in Review Manager (version 5.2). If study designs did not diff er signifi cantly, we reported the fi nal pooled eff ect size of all studies combined, irrespective of design. We assessed the proportion of variance in pooled estimates because of heterogeneity by χ² and I². A p value of less than 0·1 was deemed signifi cant. I² less than 25% was considered low heterogeneity, 25-75% was considered medium heterogeneity, and ≥75% was considered high hetero- We assessed quality according to the Newcastle-Ottawa Scale with highest quality assessed as: (1) longitudinal study design; (2) disability-free cohort at baseline; (3) measured glucose or physician-diagnosed diabetes; and (4) models adjusted for appropriate confounders including age, sex, smoking, and education, and excluding chronic diseases that might be part of the pathway from diabetes to disability. For studies reporting risk of mobility disability, objectively measured mobility was an additional quality criterion. Studies that met all quality domains were classifi ed as high quality. 20 We assessed publication and selective reporting bias by the symmetry of the funnel plot. 21 
Role of the funding source
The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had fi nal responsibility for the decision to submit for publication.
Results
Our initial search yielded 3224 articles, 98 of which had relevant titles and abstracts. After reading the full text, 44 met our inclusion criteria (fi gure 1). 15 of these were excluded at the stage of data extraction (fi gure 1). [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] A further three [37] [38] [39] did not report CIs and were not available on request but the reported point estimates of the association between diabetes and disability were included in the qualitative review.
Thus, 26 studies were included in our metaanalysis; 22 reported ORs and four reported RRs. Most studies were cross-sectional, nine were longitudinal, and one was a case-control study (table) . Although the study of Wu and colleagues 12 was longitudinal, we only included the results from their cross-sectional analysis of their baseline data because their longitudinal data reported change in disability status over time, not the risk of incident disability from diabetes. 57 Length of follow-up in the longitudinal studies ranged from 18 months 11 to 9 years. 39, 43 analysed the association between impaired glucose tolerance and disability.
Measures of ADL included bathing, dressing, eating, walking across a room, transferring from a bed or chair, and using the toilet. Measures of IADL included using the phone, shopping, and using transport. Impaired mobility was assessed by self-reported limitations in walking 0·25-0·5 miles or walking up and down stairs. Mobility was also objectively measured by physical performance tests such as walking speed, chair stands, and balance tests.
16 studies analysed 20 populations for the association between diabetes and mobility disability. Of these 16, four objectively measured mobility. 9, 42, 47, 61 Al Snih and colleagues and Gregg and colleagues reported eff ect sizes for both self-reported and objectively measured mobility limitation; only those relating to the objective measures were used in our meta-analysis. Maggi and coworkers 47 reported eff ect sizes for outcomes of several physical performance tests but no risk association for a dichotomised mobility disability outcome, therefore we could not include their fi ndings in our meta-analysis. Of the 15 included studies, 11 were cross-sectional, four longitudinal (all reported RRs), and one case-control. Two included women only.
10, 61 Maggi and coworkers 47 reported ORs for varying severity of disability ranging from 1·39 (95% CI 0·98-1·98) to 2·16 (95% CI 1·25-3·73) in women with diabetes and 1·07 (95% CI 0·72-1·58) to 2·81 (95% CI 1·44-5·41) in men with diabetes.
Pooled ORs from cross-sectional studies showed that diabetes was associated with an increased odds of mobility disability compared with no diabetes (OR 1·68, 95% CI 1·50-1·88; fi gure 2A). The case-control study reported an OR of 2·10 (95% CI 1·56-2·83). All together, the OR was 1·71 (95% CI 1·53-1·91). Metaanalysis of longitudinal studies reporting RRs showed that people with diabetes were more likely to report incident mobility disability than those without diabetes (pooled RR 1·51, 95% CI 1·38-1·64; fi gure 2B).
Our meta-analysis of the association between diabetes and IADL included ten studies, all of which reported ORs. Pooled point estimates from cross-sectional studies showed an increased risk of IADL disability with diabetes compared with no diabetes (OR 1·67, 95% CI 1·57-1·77; fi gure 3). Pooled estimates did not diff er signifi cantly between cross-sectional and longitudinal studies (p=0·17) and overall heterogeneity when cross-sectional and longitudinal studies were pooled was not signifi cant (p=0·24; I²=21%). The pooled OR from combining crosssectional and longitudinal studies was 1·65 (95% CI 1·55-1·74).
We analysed the risk of ADL disability associated with diabetes from 16 studies, representing 19 populations. 14 studies reported eff ect sizes as ORs (12 cross-sectional, two longitudinal) and two longitudinal studies reported RRs (fi gure 4A). Pooled ORs from cross-sectional studies showed that having diabetes was associated with an increased odds of diffi culties with ADL compared with no diabetes (OR 1·87; 95% CI 1·66-2·10). The pooled risk estimate from longitudinal studies was 1·48 (95% CI 1·12-1·94), which is not signifi cantly diff erent from the pooled estimate from cross-sectional studies (p=0·12). All together, the OR was 1·82 (95% CI 1·63-2·04). Pooled estimates from all studies reporting RRs for ADL disability showed an increase in the risk of disability if the person had diabetes (RR 1·82; 95% CI 1·40-2·36; fi gure 4B).
We report signifi cant, but low heterogeneity between cross-sectional studies reporting the association between 
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Odds ratio (95% CI) . Systematic exclusion of some individual studies from the analyses resulted in changes to heterogeneity and the eff ect size in the analysis of cross-sectional studies addressing the association between diabetes and mobility disability, although we could not test whether these changes were signifi cant (data not shown). Exclusion of point estimates from the study of McLaughlin and colleagues 50 decreased the overall heterogeneity to 0% (p=0·56) and slightly increased the pooled OR for mobility disability to 1·80 (95% CI 1·65-1·96) from 1·71 (1·53-1·91). None of the other studies on mobility disability reporting ORs or RRs aff ected heterogeneity or the pooled eff ect size after exclusion from our analysis (data not shown). Likewise, no signifi cant changes occurred to the heterogeneity or pooled estimates when any of the studies reporting risks of IADL disability were excluded (data not shown).
Exclusion of the study by Kalyani and colleagues 44 from the meta-analysis of ADL disability decreased the overall heterogeneity from 37% to 17% (p=0·26). The pooled eff ect size decreased from 1·82 (95% CI 1·63-2·04) to 1·76 (1·59-1·94). Exclusion of the point estimate for men in the study by Maggi and coworkers 47 also decreased heterogeneity to non-signifi cance (I²=26%; p=0·16). Exclusion of the other studies of ADL that reported ORs did not substantially aff ect heterogeneity. Only two studies in the meta-analysis of longitudinal studies of ADL disability reported RRs and heterogeneity was not signifi cant (fi gure 4).
Meta-analyses of studies that did not adjust for chronic diseases that might be in the pathway from diabetes to disability did not substantially alter the pooled eff ect sizes. None of the studies met all of our quality criteria (appendix).
We also assessed the association between diabetes and disability in studies that met our inclusion criteria but were not compatible for meta-analysis. Three studies reported eff ect sizes without CIs. Clark and coworkers 37 reported an OR of 1·27 for mobility disability within 2 years (adjusted for sociodemographic, economic, and lifestyle factors, and multiple chronic diseases) in a population aged 51-61 years, though it was not signifi cant (p>0·05). In a cross-sectional study of physical function (measured by the physical function component in the Medical Outcomes Study 36-item questionnaire) in people aged 60-70 years, Sayer and colleagues 39 reported an OR of 2·73 (p<0·001) for people with diabetes compared with those with normal glucose tolerance. Rodriguez-Saldana and coworkers 38 assessed the relation between diabetes and disability in a population in Mexico City from repeated surveys over 10 years. They reported RRs of 2·46 for ADL disability and 3·11 for IADL disability in people with diabetes compared with those without diabetes.
With regards to impaired glucose tolerance and risk of disability, Hiltunen and colleagues 43 reported an OR of 1·12 for poorer function in people with impaired glucose tolerance compared with those with normal glucose tolerance, after adjustment for age and sex. Sayer and coworkers 39 reported an OR of 1·62 (p=0·03). We could not pool these estimates because of incompatible data.
In our assessment of moderating factors, we detected no diff erence between sexes for odds of ADL or mobility disability in cross-sectional studies (data not shown). Our data were insuffi cient to analyse sex diff erences in the relation between diabetes and disability risk from longitudinal studies. We were unable to analyse the roles of duration of diabetes or degree of glycaemic control in the association between diabetes and disability. Although two studies 10, 57 investigated the eff ect of diabetes duration, the categorisations of diabetes duration were not comparable. All funnel plots looked symmetrical (appendix); however, some analyses included only a small number of studies.
Discussion
This study is the fi rst meta-analysis to estimate the magnitude of the association between diabetes and disability and shows a roughly 50-80% increased risk of disability for people with diabetes compared to people without diabetes. This risk accords with previous reviews and large longitudinal studies.
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See Online for appendix off er another perspective on the implications of diabetes and its eff ect on disability. For example, in a longitudinal study 62 of 8344 women aged older than 65 years, the yearly incidence of disability in those with diabetes was roughly 10% compared with less than 5% in those without diabetes.
The major strength of our study was the inclusion of a large number of studies with risk estimates for diff erent domains of disability. We showed a consistent association across ADL, IADL, and mobility. All but one longitudinal study analysed incident disability in a population free of disability at baseline. The consistency of our results between longitudinal and cross-sectional studies suggests little eff ect of reverse causation. Furthermore, heterogeneity between studies was low or zero for all analyses. No studies met all our quality criteria, but Volpato and colleagues 61 met all but one and reported an RR consistent with the pooled point estimates.
Misclassifi cation of diabetes status could dilute the strength of association between diabetes and disability. Self-reported diabetes status might underestimate the true prevalence of diabetes, as shown in a previous large study in which only half of patients with diabetes knew their diagnosis. 63 Furthermore, in longitudinal studies in which diabetes status is ascertained at baseline, longer follow-up is likely to be associated with misclassifi cation of no diabetes, with new cases of diabetes occurring during follow-up. We did not analyse modifi cation of risk by length of follow-up because of the small number of studies. However, the consistency of our results across studies with and without diabetes diagnosed by blood glucose analysis by a doctor suggests that this eff ect is not a major limitation.
No information was included about type or cause of diabetes-some studies might have included various types of diabetes. However, in elderly people, type 2 diabetes is predominant. Thus, we cannot establish whether the association between diabetes and disability diff ers by cause of diabetes. Furthermore, the magnitude of associations between diabetes and disability might not be generalisable to all defi nitions of disability, but the consistency of eff ect sizes across the three disability types (ADL, IADL, and mobility) suggests that this limitation is not substantial.
The mechanisms by which hyperglycaemia leads to disability are still unclear. High concentrations of glucose might lead to systemic, chronic infl ammation, which is part of a multifactorial process eventually resulting in disability. 6, 13 Some studies 64, 65 have also shown that diabetes is associated with rapid loss of skeletal muscle strength and quality, worsening with increased duration of diabetes and poor glycaemic control. The increased risk of disability from diabetes might be moderated by duration of diabetes and glycaemic control such as that measured by HbA 1C . Wu and colleagues 57 suggested that the longer the duration of diabetes, the greater the risk of disability, although this fi nding was not supported by Gregg and coworkers. 10 Poor glycaemic control and long duration of diabetes increase the risk of diabetic complications-eg, cardiovascular disease, stroke, peripheral vascular disease, renal disease, peripheral neuropathy, and retinopathy. 4, [66] [67] [68] All these complications can result in disability. No studies included in our metaanalysis investigated the eff ect of duration of diabetes or glycaemic control.
Some studies 39, 43 suggest that patients with impaired glucose tolerance have an increased risk of disability, even before progression to diabetes. Our ability to investigate this possibility was limited by the scarcity of reports analysing prediabetes. The possibility that the 
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Reynolds (2003) 54 Woo ( risk of disability increases in a graded manner from impaired glucose tolerance to diabetes and might be moderated by duration of diabetes further emphasises the need for more eff ective prevention of diabetes, particularly in middle-aged people. A large longitudinal study that measures fasting glucose, oral glucose tolerance test, HbA 1c at baseline, and multiple domains of disability over time is needed to fi ll the gaps in our understanding of the moderators of the association between diabetes, as well as the link between prediabetes and disability.
As the world's population ages, diabetes will become more common, increasing the need for disability-related health resources. Costs will be both direct (eg, for health services, assistive devices, nursing home costs) and indirect (loss of productivity both from individuals and their carers).
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